Company Filing History:
Years Active: 1997-1998
Title: Lison Bastien: Innovator in Prostaglandin Receptor Research
Introduction
Lison Bastien is a notable inventor based in St. Lazare, CA. He has made significant contributions to the field of biotechnology, particularly in the study of prostaglandin receptors. With a total of 2 patents to his name, Bastien's work has implications for various therapeutic applications.
Latest Patents
One of Lison Bastien's latest patents involves the identification of a novel prostaglandin receptor, specifically the EP2 receptor. This patent details the DNA encoding the human prostaglandin receptor EP2, which has been isolated, purified, sequenced, and expressed in host cells. The DNA encoding this novel receptor, along with the host cells expressing it, is utilized to identify modulators of the prostaglandin receptor, showcasing Bastien's innovative approach to receptor research.
Career Highlights
Lison Bastien is currently employed at Merck Frosst Canada, Inc., where he continues to advance his research in the field. His work at this prominent pharmaceutical company allows him to collaborate with leading experts and contribute to groundbreaking discoveries in medicine.
Collaborations
Some of Lison Bastien's notable coworkers include Mark Abramovitz and Mohammed Adam. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Lison Bastien's contributions to the field of prostaglandin receptor research exemplify his dedication to advancing medical science. His innovative patents and work at Merck Frosst Canada, Inc. position him as a key figure in biotechnology.